CXCR4 and adrenal cortex carcinoma: For example, some studies have reported intense overexpression of CXCR4 in patients with SCLC [30,31,32], and Bluemel et al. demonstrated feasibility of CXCR4-directed PET/CT imaging in patients with advanced adrenocortical cancer.